1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Editing Technology Market Size Growth Rate by Type (2021-2027) 1.2.2 Homologous Recombination 1.2.3 Meganuclease 1.3 Market by Application 1.3.1 Global Gene Editing Technology Market Share by Application (2021-2027) 1.3.2 Agriculture 1.3.3 Medical 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Gene Editing Technology Market Size 2.2 Gene Editing Technology Market Size by Regions 2.2.1 Gene Editing Technology Growth Rate by Regions (2021-2027) 2.2.2 Gene Editing Technology Market Share by Regions (2021-2027) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Use Cases 3 Key Players 3.1 Gene Editing Technology Revenue by Players (2020-2021) 3.2 Gene Editing Technology Key Players Headquaters and Area Served 3.3 Key Players Gene Editing Technology Product/Solution/Service 3.4 Date of Enter into Gene Editing Technology Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown by Type and by Application 4.1 Global Gene Editing Technology Market Size by Type (2021-2027) 4.2 Global Gene Editing Technology Market Size by Application (2021-2027) 5 North America 5.1 North America Gene Editing Technology Market Forecast (2021-2027) 5.2 Gene Editing Technology Key Players in North America 5.3 North America Gene Editing Technology Market Size by Type 5.4 North America Gene Editing Technology Market Size by Application 6.4.4 Canada 6 Europe 6.1 Europe Gene Editing Technology Market Forecast (2021-2027) 6.2 Gene Editing Technology Key Players in Europe 6.3 Europe Gene Editing Technology Market Size by Type 6.4 Europe Gene Editing Technology Market Size by Application 7 Japan 7.1 Japan Gene Editing Technology Market Forecast (2021-2027) 7.2 Gene Editing Technology Key Players in Europe 7.3 Japan Gene Editing Technology Market Size by Type 7.4 Japan Gene Editing Technology Market Size by Application 8 Rest of World 8.1 China 8.1.1 China Gene Editing Technology Market Analysis 8.1.2 Key Players in China 8.2 Southeast Asia 8.2.1 Southeast Asia Gene Editing Technology Market Analysis 8.2.2 Key Players in Southeast Asia 8.3 India 8.3.1 India Gene Editing Technology Market Analysis 8.3.2 Key Players in India 9 International Player Profiles 9.1 Thermo Fisher Scientific 9.1.1 Thermo Fisher Scientific Company Details 9.1.2 Thermo Fisher Scientific Description and Business Overview 9.1.3 Thermo Fisher Scientific Gene Editing Technology Introduction 9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Technology Business (2020-2021) 9.1.5 Thermo Fisher Scientific Recent Development 9.2 SIGMA ALDRICH 9.2.1 SIGMA ALDRICH Company Details 9.2.2 SIGMA ALDRICH Description and Business Overview 9.2.3 SIGMA ALDRICH Gene Editing Technology Introduction 9.2.4 SIGMA ALDRICH Revenue in Gene Editing Technology Business (2020-2021) 9.2.5 SIGMA ALDRICH Recent Development 9.3 Dharmacon 9.3.1 Dharmacon Company Details 9.3.2 Dharmacon Description and Business Overview 9.3.3 Dharmacon Gene Editing Technology Introduction 9.3.4 Dharmacon Revenue in Gene Editing Technology Business (2020-2021) 9.3.5 Dharmacon Recent Development 9.4 Cellectics 9.4.1 Cellectics Company Details 9.4.2 Cellectics Description and Business Overview 9.4.3 Cellectics Gene Editing Technology Introduction 9.4.4 Cellectics Revenue in Gene Editing Technology Business (2020-2021) 9.4.5 Cellectics Recent Development 9.5 CRISPR Therapeutics 9.5.1 CRISPR Therapeutics Company Details 9.5.2 CRISPR Therapeutics Description and Business Overview 9.5.3 CRISPR Therapeutics Gene Editing Technology Introduction 9.5.4 CRISPR Therapeutics Revenue in Gene Editing Technology Business (2020-2021) 9.5.5 CRISPR Therapeutics Recent Development 9.6 AstraZeneca 9.6.1 AstraZeneca Company Details 9.6.2 AstraZeneca Description and Business Overview 9.6.3 AstraZeneca Gene Editing Technology Introduction 9.6.4 AstraZeneca Revenue in Gene Editing Technology Business (2020-2021) 9.6.5 AstraZeneca Recent Development 9.7 Bio Rad 9.7.1 Bio Rad Company Details 9.7.2 Bio Rad Description and Business Overview 9.7.3 Bio Rad Gene Editing Technology Introduction 9.7.4 Bio Rad Revenue in Gene Editing Technology Business (2020-2021) 9.7.5 Bio Rad Recent Development 9.8 Allele Biotech 9.8.1 Allele Biotech Company Details 9.8.2 Allele Biotech Description and Business Overview 9.8.3 Allele Biotech Gene Editing Technology Introduction 9.8.4 Allele Biotech Revenue in Gene Editing Technology Business (2020-2021) 9.8.5 Allele Biotech Recent Development 9.9 Recombinetics 9.9.1 Recombinetics Company Details 9.9.2 Recombinetics Description and Business Overview 9.9.3 Recombinetics Gene Editing Technology Introduction 9.9.4 Recombinetics Revenue in Gene Editing Technology Business (2020-2021) 9.9.5 Recombinetics Recent Development 9.10 Lonza 9.10.1 Lonza Company Details 9.10.2 Lonza Description and Business Overview 9.10.3 Lonza Gene Editing Technology Introduction 9.10.4 Lonza Revenue in Gene Editing Technology Business (2020-2021) 9.10.5 Lonza Recent Development 9.11 GE Healthcare 9.11.1 GE Healthcare Company Details 9.11.2 GE Healthcare Description and Business Overview 9.11.3 GE Healthcare Gene Editing Technology Introduction 9.11.4 GE Healthcare Revenue in Gene Editing Technology Business (2020-2021) 9.11.5 GE Healthcare Recent Development 9.12 Editas Medicine 9.12.1 Editas Medicine Company Details 9.12.2 Editas Medicine Description and Business Overview 9.12.3 Editas Medicine Gene Editing Technology Introduction 9.12.4 Editas Medicine Revenue in Gene Editing Technology Business (2020-2021) 9.12.5 Editas Medicine Recent Development 9.13 Agilent Technologies 9.13.1 Agilent Technologies Company Details 9.13.2 Agilent Technologies Description and Business Overview 9.13.3 Agilent Technologies Gene Editing Technology Introduction 9.13.4 Agilent Technologies Revenue in Gene Editing Technology Business (2020-2021) 9.13.5 Agilent Technologies Recent Development 9.14 QIAGEN NV 9.14.1 QIAGEN NV Company Details 9.14.2 QIAGEN NV Description and Business Overview 9.14.3 QIAGEN NV Gene Editing Technology Introduction 9.14.4 QIAGEN NV Revenue in Gene Editing Technology Business (2020-2021) 9.14.5 QIAGEN NV Recent Development 10 Market Dynamics 10.1 Industry Trends 10.2 Market Drives 10.3 Market Challenges 10.4 Market Restraints 11 Key Findings in This Report 12 Appendix 12.1 Research Methodology 12.1.1 Methodology/Research Approach 12.1.2 Data Source 12.2 Disclaimer 12.3 Author Details

List of Tables Table 1. Global Gene Editing Technology Market Size Growth Rate by Type (2021-2027) (US$ Million) Table 2. Key Players of Homologous Recombination Table 3. Key Players of Meganuclease Table 4. Global Gene Editing Technology Market Size Growth by Application (2021-2027) (US$ Million) Table 5. Global Gene Editing Technology Market Size by Regions (2021-2027) (US$ Million) Table 6. Global Gene Editing Technology Market Share by Regions (2021-2027) Table 7. Market Top Trends Table 8. Market Use Cases Table 9. Global Gene Editing Technology Revenue by Players (2020-2021) (US$ Million) Table 10. Global Gene Editing Technology Market Share by Players (2020-2021) Table 11. Key Players Headquarters and Area Served Table 12. Key Players Gene Editing Technology Product Solution and Service Table 13. Date of Enter into Gene Editing Technology Market Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Global Gene Editing Technology Market Size by Type (2021-2027) (US$ Million) Table 16. Global Gene Editing Technology Market Size Share by Type (2021-2027) Table 17. Global Gene Editing Technology Market Size by Application (2021-2027) (US$ Million) Table 18. Global Gene Editing Technology Market Size Share by Application (2021-2027) Table 19. North America Key Players Gene Editing Technology Revenue (2020-2021) (US$ Million) Table 20. North America Key Players Gene Editing Technology Market Share (2020-2021) Table 21. North America Gene Editing Technology Market Size by Type (2021-2027) (US$ Million) Table 22. North America Gene Editing Technology Market Share by Type (2021-2027) Table 23. North America Gene Editing Technology Market Size by Application (2021-2027) (US$ Million) Table 24. North America Gene Editing Technology Market Share by Application (2021-2027) Table 25. Europe Key Players Gene Editing Technology Revenue (2020-2021) (US$ Million) Table 26. Europe Key Players Gene Editing Technology Market Share (2020-2021) Table 27. Europe Gene Editing Technology Market Size by Type (2021-2027) (US$ Million) Table 28. Europe Gene Editing Technology Market Share by Type (2021-2027) Table 29. Europe Gene Editing Technology Market Size by Application (2021-2027) (US$ Million) Table 30. Europe Gene Editing Technology Market Share by Application (2021-2027) Table 31. Japan Key Players Gene Editing Technology Revenue (2020-2021) (US$ Million) Table 32. Japan Key Players Gene Editing Technology Market Share (2020-2021) Table 33. Japan Gene Editing Technology Market Size by Type (2021-2027) (US$ Million) Table 34. Japan Gene Editing Technology Market Share by Type (2021-2027) Table 35. Japan Gene Editing Technology Market Size by Application (2021-2027) (US$ Million) Table 36. Japan Gene Editing Technology Market Share by Application (2021-2027) Table 37. Key Players in China Table 38. Key Players in Southeast Asia Table 39. Key Players in India Table 40. Thermo Fisher Scientific Company Details Table 41. Thermo Fisher Scientific Description and Business Overview Table 42. Thermo Fisher Scientific Gene Editing Technology Product Table 43. Thermo Fisher Scientific Revenue in Gene Editing Technology Business 2020 and 2021 Table 44. Thermo Fisher Scientific Recent Development Table 45. SIGMA ALDRICH Company Details Table 46. SIGMA ALDRICH Description and Business Overview Table 47. SIGMA ALDRICH Gene Editing Technology Product Table 48. SIGMA ALDRICH Revenue in Gene Editing Technology Business 2020 and 2021 Table 49. SIGMA ALDRICH Recent Development Table 50. Dharmacon Company Details Table 51. Dharmacon Description and Business Overview Table 52. Dharmacon Gene Editing Technology Product Table 53. Dharmacon Revenue in Gene Editing Technology Business 2020 and 2021 Table 54. Dharmacon Recent Development Table 55. Cellectics Company Details Table 56. Cellectics Description and Business Overview Table 57. Cellectics Gene Editing Technology Product Table 58. Cellectics Revenue in Gene Editing Technology Business 2020 and 2021 Table 59. Cellectics Recent Development Table 60. CRISPR Therapeutics Company Details Table 61. CRISPR Therapeutics Description and Business Overview Table 62. CRISPR Therapeutics Gene Editing Technology Product Table 63. CRISPR Therapeutics Revenue in Gene Editing Technology Business 2020 and 2021 Table 64. CRISPR Therapeutics Recent Development Table 65. AstraZeneca Company Details Table 66. AstraZeneca Description and Business Overview Table 67. AstraZeneca Gene Editing Technology Product Table 68. AstraZeneca Revenue in Gene Editing Technology Business 2020 and 2021 Table 69. AstraZeneca Recent Development Table 70. Bio Rad Company Details Table 71. Bio Rad Description and Business Overview Table 72. Bio Rad Gene Editing Technology Product Table 73. Bio Rad Revenue in Gene Editing Technology Business 2020 and 2021 Table 74. Bio Rad Recent Development Table 75. Allele Biotech Company Details Table 76. Allele Biotech Description and Business Overview Table 77. Allele Biotech Gene Editing Technology Product Table 78. Allele Biotech Revenue in Gene Editing Technology Business 2020 and 2021 Table 79. Allele Biotech Recent Development Table 80. Recombinetics Company Details Table 81. Recombinetics Description and Business Overview Table 82. Recombinetics Gene Editing Technology Product Table 83. Recombinetics Revenue in Gene Editing Technology Business 2020 and 2021 Table 84. Recombinetics Recent Development Table 85. Lonza Company Details Table 86. Lonza Description and Business Overview Table 87. Lonza Gene Editing Technology Product Table 88. Lonza Revenue in Gene Editing Technology Business 2020 and 2021 Table 89. Lonza Recent Development Table 90. GE Healthcare Company Details Table 91. GE Healthcare Description and Business Overview Table 92. GE Healthcare Gene Editing Technology Product Table 93. GE Healthcare Revenue in Gene Editing Technology Business 2020 and 2021 Table 94. GE Healthcare Recent Development Table 95. Editas Medicine Company Details Table 96. Editas Medicine Description and Business Overview Table 97. Editas Medicine Gene Editing Technology Product Table 98. Editas Medicine Revenue in Gene Editing Technology Business 2020 and 2021 Table 99. Editas Medicine Recent Development Table 100. Agilent Technologies Company Details Table 101. Agilent Technologies Description and Business Overview Table 102. Agilent Technologies Gene Editing Technology Product Table 103. Agilent Technologies Revenue in Gene Editing Technology Business 2020 and 2021 Table 104. Agilent Technologies Recent Development Table 105. QIAGEN NV Company Details Table 106. QIAGEN NV Description and Business Overview Table 107. QIAGEN NV Gene Editing Technology Product Table 108. QIAGEN NV Revenue in Gene Editing Technology Business 2020 and 2021 Table 109. QIAGEN NV Recent Development Table 110. Gene Editing Technology Market Trends Table 111. Gene Editing Technology Market Drivers Table 112. Gene Editing Technology Market Challenges Table 113. Gene Editing Technology Market Restraints Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Editing Technology Market Share by Type in 2021 & 2027 Figure 2. Homologous Recombination Features Figure 3. Meganuclease Features Figure 4. Global Gene Editing Technology Market Share by Application in 2021 & 2027 Figure 5. Agriculture Case Studies Figure 6. Medical Case Studies Figure 7. Other Case Studies Figure 8. Gene Editing Technology Report Years Considered Figure 9. Global Gene Editing Technology Market Size and Growth Rate (2020-2027) (US$ Million) Figure 10. Global Gene Editing Technology Market Share by Regions (2020-2027) Figure 11. Global Gene Editing Technology Market Share by Players in 2021 Figure 12. Global Gene Editing Technology Market Size Market Share by Type (2021-2027) Figure 13. Global Gene Editing Technology Market Size Market Share by Application (2021-2027) Figure 14. Global Gene Editing Technology Revenue Market Share by Application in 2021 Figure 15. North America Gene Editing Technology Market Size 2021-2027 (US$ Million) Figure 16. Europe Gene Editing Technology Market Size 2021-2027 (US$ Million) Figure 17. Japan Gene Editing Technology Market Size 2021-2027 (US$ Million) Figure 18. Gene Editing Technology Market Size in China (2021-2027) (US$ Million) Figure 19. Gene Editing Technology Market Size in Southeast Asia (2021-2027) (US$ Million) Figure 20. Gene Editing Technology Market Size in India (2021-2027) (US$ Million) Figure 21. Bottom-up and Top-down Approaches for This Report Figure 22. Data Triangulation Figure 23. Key Executives Interviewed

Thermo Fisher Scientific SIGMA ALDRICH Dharmacon Cellectics CRISPR Therapeutics AstraZeneca Bio Rad Allele Biotech Recombinetics Lonza GE Healthcare Editas Medicine Agilent Technologies QIAGEN NV